{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:25:46Z","timestamp":1774952746683,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jaad.2013.12.019","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T11:58:10Z","timestamp":1397735890000},"page":"821.e1-821.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The spectrum of oculocutaneous disease"],"prefix":"10.1016","volume":"70","author":[{"given":"Antoinette","family":"Day","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda K.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahir","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Alan","family":"Menter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.12.019_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/DAD.0b013e3181961861","article-title":"Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature","volume":"31","author":"Deprez","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2013.12.019_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000089274","article-title":"Clinical analysis of benign eyelid and conjunctival tumors","volume":"220","author":"Chi","year":"2006","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jaad.2013.12.019_bib3","series-title":"Atlas of clinical ophthalmology","author":"Basak","year":"2013"},{"key":"10.1016\/j.jaad.2013.12.019_bib4","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/IOP.0b013e31821f1df3","article-title":"Intralesional interferon for extensive squamous papilloma of the eyelid margin","volume":"28","author":"Lee","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2013.12.019_bib5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.12.019_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sder.2004.01.002","article-title":"Sturge-Weber syndrome","volume":"23","author":"Baselga","year":"2004","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2013.12.019_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0887-8994(97)00093-3","article-title":"Enhanced magnetic resonance imaging of leptomeningeal angiomatosis","volume":"17","author":"Sugama","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaad.2013.12.019_bib8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.5301\/ejo.5000322","article-title":"Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome","volume":"23","author":"Thapa","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/jp.2011.28","article-title":"Use of propranolol for treatment of hemangiomas in PHACE syndrome","volume":"31","author":"Solomon","year":"2011","journal-title":"J Perinatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/159101991101700201","article-title":"Adult presentation of PHACES syndrome","volume":"17","author":"Arora","year":"2011","journal-title":"Interv Neuroradiol"},{"key":"10.1016\/j.jaad.2013.12.019_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaapos.2004.08.012","article-title":"Ocular and systemic manifestations of PHACES (Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects and coarctation of the Aorta, Eye abnormalities, and Sternal abnormalities or ventral developmental defects) syndrome","volume":"9","author":"Kronenberg","year":"2005","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaad.2013.12.019_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1542\/peds.2009-0082","article-title":"Consensus statement on diagnostic criteria for PHACE syndrome","volume":"124","author":"Metry","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.12.019_bib13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00417-012-2115-4","article-title":"Morning glory disc anomaly with contractile movements","volume":"250","author":"Sawada","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.otc.2012.03.001","article-title":"Current management of infantile hemangiomas and their common associated conditions","volume":"45","author":"Hartzell","year":"2012","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.jaad.2013.12.019_bib15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bjo.2010.192245","article-title":"The use of propranolol in the treatment of periocular infantile haemangiomas: a review","volume":"95","author":"Claerhout","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1525-1470.2011.01345.x","article-title":"Propranolol for infantile hemangiomas","volume":"28","author":"Bagazgoitia","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaad.2013.03.001","article-title":"What's new in pediatric dermatology? Part II. Treatment","volume":"68","author":"Pride","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/09273940903144705","article-title":"Vitreous metastases of primary cutaneous B-cell lymphoma","volume":"17","author":"Chong","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2013.12.019_bib19","doi-asserted-by":"crossref","first-page":"v177","DOI":"10.1093\/annonc\/mdq183","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Willemze","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2013.12.019_bib20","series-title":"Dermatology","year":"2012"},{"key":"10.1016\/j.jaad.2013.12.019_bib21","first-page":"182","article-title":"Ocular findings in cutaneous T-cell lymphoma","volume":"23","author":"Leib","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bjo.77.2.126","article-title":"Ocular involvement in mycosis fungoides","volume":"77","author":"Leitch","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib23","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/j.1755-3768.2009.01797.x","article-title":"Diagnosis of systemic metastatic retinal lymphoma","volume":"89","author":"Cao","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0008-4182(05)80058-4","article-title":"Extranodal B-cell lymphoma of the uvea: a case report","volume":"40","author":"Coutinho","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib25","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-07-202895","article-title":"How I treat mycosis fungoides and S\u00e9zary syndrome","volume":"114","author":"Prince","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.12.019_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.optm.2010.10.009","article-title":"Ocular manifestations of multiple myeloma: three cases and a review of the literature","volume":"82","author":"Chin","year":"2011","journal-title":"Optometry"},{"key":"10.1016\/j.jaad.2013.12.019_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.1991.01680010079012","article-title":"Cutaneous manifestations of multiple myeloma","volume":"127","author":"Kois","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archderm.1985.01660060109033","article-title":"Follicular hyperkeratosis and cryocrystalglobulinemia syndrome. Occurrence in a patient with multiple myeloma","volume":"121","author":"Lukitsch","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ophtha.2004.11.036","article-title":"Orbital invasion by periocular basal cell carcinoma","volume":"112","author":"Leibovitch","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2013.12.019_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2011.08.004","article-title":"Risk factors for orbital exenteration in periocular basal cell carcinoma","volume":"153","author":"Iuliano","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.iop.0000225421.60264.68","article-title":"Review of patients with basal cell nevus syndrome","volume":"22","author":"Taylor","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2013.12.019_bib32","first-page":"23","article-title":"Nevoid basal cell carcinoma syndrome","volume":"17","author":"Leger","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2013.12.019_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10006-009-0169-1","article-title":"Basal cell nevus syndrome: clinical and genetic diagnosis","volume":"13","author":"Garcia de Marcos","year":"2009","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.jaad.2013.12.019_bib34","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.12.019_bib35","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.12.019_bib36","first-page":"134","article-title":"Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers","volume":"3","author":"Sun","year":"2009","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.jaad.2013.12.019_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1442-9071.2006.01411.x","article-title":"Periocular squamous cell carcinoma","volume":"35","author":"Limawararut","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib38","first-page":"585","article-title":"Periocular squamous cell carcinoma","volume":"34","author":"Thosani","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2013.12.019_bib39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1442-9071.2011.02564.x","article-title":"Eyelid squamous cell carcinoma in situ treated with topical 5-fluorouracil","volume":"39","author":"Sharkawi","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib40","first-page":"442","article-title":"Clinicopathologic features and prognostic factors of malignant eyelid tumors","volume":"6","author":"Wang","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0974-620X.71885","article-title":"Sebaceous gland carcinoma of the eyelid","volume":"3","author":"Wali","year":"2010","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molmed.2004.01.006","article-title":"DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention","volume":"10","author":"Kruse","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaad.2013.12.019_bib43","series-title":"Fitzpatrick's dermatology in general medicine","author":"Fitzpatrick","year":"2008"},{"key":"10.1016\/j.jaad.2013.12.019_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archdermatol.2010.105","article-title":"Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study","volume":"146","author":"Blake","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib45","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.23963","article-title":"Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms","volume":"113","author":"Dores","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2013.12.019_bib46","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0161-6420(02)01239-3","article-title":"Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2013.12.019_bib47","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2013.12.019_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1740774511419684","article-title":"Collaborative ocular melanoma study randomized trial of I-125 brachytherapy","volume":"8","author":"Hawkins","year":"2011","journal-title":"Clin Trials"},{"key":"10.1016\/j.jaad.2013.12.019_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.survophthal.2008.02.003","article-title":"Cutaneous malignant melanoma metastatic to the eye, lids, and orbit","volume":"53","author":"Rosenberg","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clindermatol.2008.09.010","article-title":"Ocular melanoma: relatively rare but requiring respect","volume":"27","author":"Shields","year":"2009","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib51","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.optm.2009.03.017","article-title":"Ocular metastasis of cutaneous malignant melanoma","volume":"80","author":"Ullah","year":"2009","journal-title":"Optometry"},{"key":"10.1016\/j.jaad.2013.12.019_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00417-010-1443-5","article-title":"Posterior capsule opacity as initial manifestation of metastatic cutaneous melanoma","volume":"249","author":"Solomon","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-620X.94718","article-title":"Choroidal melanoma","volume":"5","author":"Singh","year":"2012","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000335627","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Harr","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaad.2013.12.019_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","article-title":"Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications","volume":"116","author":"Sotozono","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2013.12.019_bib56","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/ICO.0b013e31823d02a8","article-title":"Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a case-control study","volume":"31","author":"Hsu","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jaad.2013.12.019_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sder.2008.07.002","article-title":"Preventing and managing the side effects of isotretinoin","volume":"27","author":"Brelsford","year":"2008","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2013.12.019_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14740338.3.2.119","article-title":"Safety and side effects of the\u00a0acne drug, oral isotretinoin","volume":"3","author":"Charakida","year":"2004","journal-title":"Exp Opin Drug Saf"},{"key":"10.1016\/j.jaad.2013.12.019_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/15569527.2012.676121","article-title":"Premacular hemorrhage due to isotretinoin use","volume":"32","author":"Onder","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jaad.2013.12.019_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/02713683.2010.486520","article-title":"Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? Observational report on six patients: occurrence of uveitis following etanercept treatment","volume":"35","author":"Kakkassery","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jaad.2013.12.019_bib61","first-page":"15","article-title":"New-onset psoriasis associated with adalimumab: a report of two cases","volume":"17","author":"Glenn","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2013.12.019_bib62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3899\/jrheum.110865","article-title":"Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease","volume":"39","author":"Gaujoux-Viala","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/09273948.2010.531176","article-title":"TNF inhibitors for uveitis: balancing efficacy and safety","volume":"18","author":"Cunnngham","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaad.2013.12.019_bib64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12664-011-0130-8","article-title":"Infliximab induced endophthalmitis in a patient of fistulizing Crohn's disease","volume":"30","author":"Kochhar","year":"2011","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.12.019_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0105-1873.2004.00311.x","article-title":"Eyelid dermatitis: A report of 215 patients","volume":"50","author":"Guin","year":"2004","journal-title":"Contact Derm"},{"key":"10.1016\/j.jaad.2013.12.019_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib67","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.iac.2005.05.006","article-title":"Effects of glucocorticosteroids on the skin and eye","volume":"25","author":"Beltrani","year":"2005","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2013.12.019_bib68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archopht.1964.00970020771005","article-title":"The effect of topical corticosteroids in secondary glaucomas","volume":"72","author":"Becker","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(69)92454-4","article-title":"Ocular effects of topical and systemic corticosteroids","volume":"294","author":"David","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.12.019_bib70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bjo.67.7.487","article-title":"Steroid responsiveness in connective tissue diseases","volume":"67","author":"Gaston","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib71","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib72","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1442-9071.2004.00787.x","article-title":"Glaucoma from topical corticosteroids to the eyelids","volume":"32","author":"Garrott","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib73","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archderm.1976.01630330080032","article-title":"Glaucoma from topically applied steroids","volume":"112","author":"Zugerman","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1976.tb00830.x","article-title":"Glaucoma following the application of corticosteroid to the skin of the eyelids","volume":"95","author":"Cubey","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib75","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0190-9622(83)80021-8","article-title":"Glaucoma following the prolonged use of topical steroid medication to the eyelids","volume":"8","author":"Eisenlohr","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2230.2004.01610.x","article-title":"Glaucoma induced by periorbital topical steroid use \u2013 a rare complication","volume":"29","author":"Sahni","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaad.2010.01.035","article-title":"Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts","volume":"64","author":"Haeck","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1067\/mjd.2001.116220","article-title":"The penetration of 0.005% fluticasone propionate ointment in eyelid skin","volume":"45","author":"Tan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib79","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/bjo.51.8.554","article-title":"Examination for posterior subcapsular cataracts in patients treated with topical steroids","volume":"51","author":"Williamson","year":"1967","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2013.12.019_bib81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1440-1843.2005.00745.x","article-title":"Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases","volume":"10","author":"Hirano","year":"2005","journal-title":"Respirology"},{"key":"10.1016\/j.jaad.2013.12.019_bib82","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3748\/wjg.v13.i22.3137","article-title":"Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C","volume":"13","author":"Sene","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.12.019_bib83","first-page":"439","article-title":"Eye complications of cetuximab therapy","volume":"16","author":"Melichar","year":"2007","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.jaad.2013.12.019_bib84","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2230.2008.02842.x","article-title":"Trichomegaly of the eyelashes following treatment with cetuximab","volume":"34","author":"Vaccaro","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1610-0387.2005.05058.x","article-title":"The management of skin reactions in cancer patients receiving epidermal growth factor receptor\u00a0targeted therapies","volume":"3","author":"Segaert","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2013.12.019_bib86","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and\u00a0management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2013.12.019_bib87","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(81)70065-3","article-title":"Antimalarials","volume":"4","author":"Koranda","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib88","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/eye.2011.245","article-title":"Humphrey visual field findings in hydroxychloroquine toxicity","volume":"25","author":"Anderson","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jaad.2013.12.019_bib89","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1562\/0031-8655(1999)069<0282:PSOAD>2.3.CO;2","article-title":"Photophysical studies on antimalarial drugs","volume":"69","author":"Motten","year":"1999","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jaad.2013.12.019_bib90","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2133.1994.tb08593.x","article-title":"Ocular toxicity of antimalarials in dermatology: a survey of current practice","volume":"131","author":"Cox","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.12.019_bib91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0049-0172(87)90023-0","article-title":"Antimalarials in rheumatology: efficacy and safety","volume":"16","author":"Maksymowych","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.12.019_bib92","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2013.12.019_bib93","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2013.4244","article-title":"Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging","volume":"131","author":"Mititelu","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib94","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2165\/00003495-199345060-00007","article-title":"Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders","volume":"45","author":"Faulds","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2013.12.019_bib95","first-page":"465","article-title":"Ocular and visual side effects of systemic cyclosporine","volume":"24","author":"Apaydin","year":"1992","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib96","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0021-5155(03)00020-0","article-title":"Influence of cyclosporin on steroid-induced cataracts after renal transplantation","volume":"47","author":"Nakamura","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaad.2013.12.019_bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/mi.4.2.7","article-title":"Biochemical mechanisms of cyclosporine neurotoxicity","volume":"4","author":"Serkova","year":"2004","journal-title":"Mol Interv"},{"key":"10.1016\/j.jaad.2013.12.019_bib98","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214009785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214009785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:30:10Z","timestamp":1759271410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214009785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0190962214009785"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.12.019","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of oculocutaneous disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}